ASAM's Live Learning Center releases new content from the ASAM 2011 Course on State of the Art in Addiction Medicine!
All sessions from the March issue of E2 include content from State of the Art. This issue's featured session has been made available at no cost by an unrestricted educational grant from Titan Pharmaceuticals, Inc. All State of the Art sessions combined provide 22 hours of CME. Attendees from State of the Art will be able to access all sessions as part of registration fees from the course.
|
Use and Abuse of Prescription Opioids: Current Evidence
Topics from this session include:
Keynote Address from ONDCP: The Administration's Prescription Drug Abuse Action Plan, Abuse-Deterrent and Tamper-Resistant Opioid Formulations: What Is Their Role in Preventing Prescription Drug Abuse?, and more.
MORE
*This session is being supported by an unrestricted educational grant from Titan Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
|
|
|
Best Practices in Buprenorphine Treatment for Opioid Dependence
March 16, 2012, Westport, MA
This course is designed for physicians who currently treat opioid addiction in a variety of clinical settings and other health care professionals who provide clinical and/or logistical support for these physicians will also benefit. The course presentations will provide strategies and resources to support effective treatment of opioid addiction and share best clinical practices.
*Registration now open!
43rd Annual Medical-Scientific Conference
April 19-22, 2012, Atlanta, GA
ASAM's annual conference is the leading conference solely focused on clinically proven methods of treatment, education and the prevention of addictions.
*Registration now open!
Main Program
Ruth Fox Course for Physicians
April 19, 2012, Atlanta, GA
Pain & Addiction: Common Threads
April 19, 2012, Atlanta, GA
|
|
|
|
Mobile version
